Reference
Kunisaki R, et al. Double-dose infliximab therapy in Crohns disease: Appropriate time to evaluate the efficacy, long-term efficacy and safety. Journal of Crohn's and Colitis 11 (Suppl. 1): S327-S328, Feb 2017. Available from: URL: http://doi.org/10.1093/ecco-jcc/jjx002.613 [abstract] - Japan
Rights and permissions
About this article
Cite this article
Infliximab. Reactions Weekly 1696, 204 (2018). https://doi.org/10.1007/s40278-018-44392-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44392-2